How I manage pregnancy in women with Glanzmann thrombasthenia.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
28 04 2022
Historique:
received: 25 10 2021
accepted: 02 03 2022
pubmed: 15 3 2022
medline: 3 5 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

Glanzmann thrombasthenia (GT) is a rare inherited platelet function disorder caused by a quantitative and/or qualitative defect of the αIIbβ3 integrin. Pregnancy and delivery are recognized risk periods for bleeding in women with GT. The newborn may also be affected by fetal and neonatal immune thrombocytopenia induced by the transplacental passage of maternal anti-αIIbβ3 antibodies, which can lead to severe hemorrhage and fetal loss. Pregnancy in women with GT thus requires a multidisciplinary approach, including prepregnancy counseling and a treatment plan for delivery for both the mother and child. In this article, we summarize the current knowledge on pregnancy in women with GT and describe how we manage this severe platelet disorder in our clinical practice.

Identifiants

pubmed: 35286390
pii: S0006-4971(22)00374-3
doi: 10.1182/blood.2021011595
doi:

Substances chimiques

Platelet Glycoprotein GPIIb-IIIa Complex 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2632-2641

Informations de copyright

© 2022 by The American Society of Hematology.

Auteurs

Mathieu Fiore (M)

Hematology Laboratory, Reference Center for Inherited Platelet Disorders, University Hospital of Bordeaux, Pessac, France.
Biology of Cardiovascular Diseases, INSERM U1034, Pessac, France.

Loïc Sentilhes (L)

Department of Obstetrics and Gynecology, University Hospital of Bordeaux, Pellegrin Hospital, Bordeaux, France.

Roseline d'Oiron (R)

Reference Center for Hemophilia and Other Rare Inherited Bleeding Disorders, Bicêtre Hospital APHP, Le Kremlin-Bicêtre, France; and.
Hemostasis, Inflammation, and Thrombosis (HITh), UMR_S1176, INSERM, Paris-Saclay University, Le Kremlin-Bicêtre, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH